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Abstract
Neurological manifestations in pandemics frequently cause short and long-term consequences which are frequently over-
looked. Despite advances in the treatment of infectious diseases, nervous system involvement remains a challenge, with 
limited treatments often available. The under-recognition of neurological manifestations may lead to an increase in the burden 
of acute disease as well as secondary complications with long-term consequences. Nervous system infection or dysfunc-
tion during pandemics is common and its enduring consequences, especially among vulnerable populations, are frequently 
forgotten. An improved understanding the possible mechanisms of neurological damage during epidemics, and increased 
recognition of the possible manifestations is fundamental to bring insights when dealing with future outbreaks. To reverse 
this gap in knowledge, we reviewed all the pandemics, large and important epidemics of human history in which neurologi-
cal manifestations are evident, and described the possible physiological processes that leads to the adverse sequelae caused 
or triggered by those pathogens.
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Introduction
Pandemics are large-scale outbreaks of infectious disease 
that can cause an excess in morbidity and mortality globally, 
or at least over a wide geographic area, and lead to socio-
economic disruption. Increase in global travel, urbanisation, 
climate change, environmental degradation, displacement 
and consumption of wild animals are factors thought to have 
increased the likelihood of pandemics during the past cen-
tury [79]. The majority of pathogens responsible for out-
breaks can cause neurologic illness, which are frequently 
overlooked, under-reported and under-diagnosed. Even in 
tertiary centres of developed countries, up to 30% of patients 
with a CNS infection never receive an etiological diagno-
sis [135], and in low resource settings lacking diagnostic 
tools, neurological manifestations are often poorly charac-
terised. Aside from the associated mortality, neurological 
involvement of infectious disease can lead to prolonged 
hospital stay and significantly increase rehabilitation time 
and long-term care needs after discharge [135], posing a 
far-reaching socioeconomic burden.
As the world deals with the Sars-CoV2 pandemic, reports 
of neurologic manifestations have increased. Understand-
ing neurological complications of previous pandemics, and 
the pathophysiological mechanisms that underlie them, are 
fundamental to place the current situation in perspective, and 
help address the enduring consequences once current waves 
of acute infection subside. This narrative review assesses the 
neurological manifestations of past and current pandemics, 
to aid our understanding of the current pandemic and pre-
pare for future outbreaks.
Mechanisms of pathogen‑mediated 
neurological disease
Pathogens can lead to nervous system impairment through 
multiple mechanisms. There may be direct infection and rep-
lication leading to the clinical syndromes of encephalitis, 
myelitis and meningitis [65]. Para-infectious complications 
such as sepsis and metabolic dysfunction related and coag-
ulopathy can lead to encephalopathy and vascular events. 
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The infection can also trigger an indirect immune-mediated 
attack both in the central and peripheral nervous system 
[32], as seen in Guillain–Barré syndromes (GBS) or acute 
disseminated encephalomyelitis (ADEM). Finally, some 
viruses can persist mutated or latent in the central nervous 
system (CNS) or peripheral ganglia, leading to potential late 
reactivation and clinical disease. Further details are provided 
in Table 1; Fig. 1.
Pathogens responsible for pandemics 
and important epidemics 
throughout history
Pathogens are divided according to the main mode of 
transmission (vector-borne, water/food-borne and direct 
or indirect with infected individuals). Its features, includ-
ing notable pandemics, non-neurological and neurological 
manifestations may be found in Fig. 2 and Table 2. We have 
summarised imaging and laboratory findings in Table 3. A 
more complete description of the neurological manifesta-
tions follows.  
Vector‑borne
Bubonic plague
The first Plague pandemic, known as the Plague of Justin-
ian, occurred during the sixth century and is believed to 
have hastened the end of the Roman Empire. The second 
commenced with a wave known as the “Black Death” and is 
estimated to have resulted in the deaths of over 100 million 
people; the highest of any pandemic in history. Currently, 
most human cases are located in Africa, and annual epidem-
ics are reported in Madagascar [156]. Meningitis is reported 
in up to 7% of all patients, typically after the 1st week in 
those who received incomplete or delayed treatment for the 
bubonic form. Younger patients have higher incidence of 
Yersinia meningitis (around 11% of children) [8, 14, 82]. It 
presents as a bacterial meningitis, with neutrophilic pleocy-
tosis in the CSF. The gold standard for diagnosis is the cul-
ture of Y. pestis in blood, sputum, bubo aspirate or CSF, but 
the bacteria can also be detected using point of care testing 
with immunochromatographic assays or quantitative PCR in 
portable thermocyclers [35, 158].
West Nile virus (WNV)
This virus was first identified in the West Nile province of 
Uganda in 1937 [122]. In 1999 an outbreak occurred in 
New York which spread to the rest of the Americas, lead-
ing to the largest epidemics of meningitis or encephalitis 
ever reported in the western hemisphere [69]. Under 1% of 
infected individuals developed the neuroinvasive disease, 
but the incidence is higher among those > 65 years, which 
also have higher mortality. The neurologic syndromes can 
overlap and be divided in meningitis, meningoencephalitis, 
and acute flaccid paralysis secondary to anterior myelitis and 
typically occurs in the acute phase of the disease. Extrapy-
ramidal signs are seen in some encephalitic cases during the 
acute illness, and may be transient or last months after the 
resolution of the disease. Seizures and encephalopathy have 
also been reported [123].
Japanese encephalitis
Large epidemics of Japanese encephalitis Virus (JEV) occur 
every 2–15 years in South-East Asia and Western Pacific, 
making it the world’s most commonly diagnosed epidemic 
encephalitis (~ 70,000 cases/year). Among the arthropod-
borne viruses, JEV leads to the greatest loss of disability-
adjusted life years, due to the frequent neurological seque-
lae of the condition. While the majority of infections are 
asymptomatic or mild, 0.1–1% cause encephalitis, mainly 
in children. It manifests in the acute phase of the disease. 
Symptoms include impaired consciousness, headache, vom-
iting, and seizures. Pyramidal and extrapyramidal signs, 
involvement of cranial nerves, eye movement abnormalities 
and anterior myelitis are described. Similar neurological fea-
tures are seen in adults. Other immunological manifestations 
include GBS, ADEM, transverse myelitis and N-methyl-
d-aspartate (NMDA) receptor encephalitis, weeks after the 
onset of the viral illness. Approximately one-fifth of patients 
with JEV-encephalitis die and 44% of those with neurologi-
cal involvement have incomplete recovery [140].
Zika
The Zika virus was described in Uganda in 1947 and has 
caused outbreaks in Asia and the Pacific. In 2014–2016 it 
caused an epidemic of microcephaly among newborns in 
the northeast of Brazil [31]. The congenital Zika syndrome 
occurs in 5–14% of pregnancies of infected mothers, and 
includes severe microcephaly, skull collapse, subcortical 
calcifications, corpus callosum anomalies, decreased white 
matter, ventriculomegaly, cerebral cortex thinning, abnor-
mal gyral patterns, vermis hypoplasia, chorioretinal atrophy, 
focal pigmented mottling of the retina, optic nerve atrophy 
and congenital contractures [90, 94]. Zika virus-associated 
GBS (both axonal and demyelinating) has been described 
5–15 days after the acute disease [94].
Chikungunya fever
Chikungunya virus was isolated during an outbreak in 1952 
in Tanzania, and significant epidemics have been described 
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Table 1  Mechanisms of pathogen-induced neurological injury
Mechanisms Description Neurologic manifestations
Direct invasion
Blood brain barrier (BBB) (haematological 
entry)
Penetration of endothelial barriers via (BBB 
disruption associated with acute host inflam-
matory responses may facilitate invasion):
Transcellular penetration (using pinocytosis or 
receptor-mediated entry)
Paracellular entry (by disrupting tight junc-
tions)
Via entry of infected leukocytes from the 
peripheral circulation into the CNS (Trojan 






Peripheral nerves (trans-synaptic spread) Pathogens:
Move along peripheral nerves via retrograde 
(from axon terminal to cell body) or antero-
grade (from cell body to axon terminal) 
transport
Invade the PNS by binding to receptors on 
axons of sensory, autonomic and motor neu-
rons, including the olfactory and vagal nerves 
[68, 77, 84, 116, 142]
Para-infectious
Sepsis-associated Diffuse disturbance of brain function as a 
consequence of the systemic inflammatory 
response of sepsis [45, 148]
Presents as impaired attention and arousal 
[165]
Release of inflammatory mediators affecting 
both the BBB and the cerebral microcircula-
tion [120] (“cytokine storm”)
Encephalopathy
Acute haemorrhagic leukoencephalitis (AHL)





Electrolyte imbalances (hyponatremia or 





Secondary to coagulopathy and vasculitis Hyperinflammation in SIRS and sepsis leads to 
coagulopathy and a prothrombotic state
Both direct pathogen invasion and the proin-
flammatory state of sepsis lead to endothe-
lial damage [144], which then shifts to a 
procoagulant state and has increased vascular 
permeability [57, 126]
Infections may cause vasculitis, either due 
to pathogen invasion, exaggerated immune 
response, or immune dysregulation triggered 






Autoimmune Triggered especially by viruses, which serve as 
antigenic stimulus and lead to lesions of the 
PNS and CNS
Associated with molecular mimicry between 
the pathogen and molecules on the axolem-
mal surface, glial membranes at the node 
of Ranvier [150] or myelin proteins of the 
host, which leads to T-cell activation and an 
autoimmune response [106]
Guillain-Barré syndromes
Acute disseminated encephalomyelitis 
(ADEM)
Transverse myelitis
Acute motor axonal neuropathy (AMAN)
Acute inflammatory demyelinating polyneu-
ropathy (AIDP)
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worldwide. The most recent started in 2013, affecting the 
Southern USA, Mexico, Central and South America, with 
over 2 million infections reported [146]. Young children and 
older adults are at a higher risk of complications, which 
may affect approximately one percent of infected individu-
als. Encephalopathy and encephalitis are caused by direct 
viral invasion and manifest early during the infection [19]. 
Myelitis can occur either in the acute phase or later in the 
course of the disease. Tardive post-infectious complications, 
thought to be autoimmune in nature, include ADEM, optic 
neuropathy, GBS, brainstem encephalitis and Bickerstaff’s 
encephalitis-Miller-Fisher overlap [19].
Table 1  (continued)
Mechanisms Description Neurologic manifestations
Persistence and latency of viral infections After direct invasion of the nervous system
Persistent viral infections: continuous viral 
replication
Latent viral infections: dormant state with 
minimal or no production of viral material 
[84].Can be reactivated upon host immuno-
suppression, and the activation of both innate 
and adaptive immune system can disrupt 
CNS homeostasis [65]
Neurocognitive disorders (HIV)
Subacute sclerosing panencephalitis (measles)
BBB blood–brain-barrier, PNS peripheral nervous system, CNS central nervous system, AHL acute haemorrhagic leukoencephalitis, ADEM 
acute disseminated encephalomyelitis, HIV human immunodeficiency virus
Fig. 1  Mechanisms of injury to the nervous system




Enteroviruses cause over 90% of viral meningitis in children 
under 10 years and is most frequently by echoviruses and 
Coxsackie-B [77]. Two enteroviruses that caused epidem-
ics and remarkable neurological manifestations are detailed 
below.
Poliovirus
Poliomyelitis was sporadically reported until the end of 
the nineteenth century, when large summer epidemics in 
North America and Europe began occurring annually [96]. 
The development and implementation of vaccination pro-
grammes since 1955 decreased its incidence dramatically, 
though outbreaks still occur in Africa and Asia, and it is 
endemic in Nigeria, Afghanistan and Pakistan. Around 1 in 
150 infections will lead to paralytic poliomyelitis [96]. When 
the virus reaches the CNS, there is a meningitic phase fol-
lowed by spinal poliomyelitis and onset of an acute flaccid 
paralysis secondary to anterior myelitis, early in the course 
of the infection. After a period of stable neurological func-
tion ( ≥ 15 years), 30–40% of polio survivors develop pro-
gressive and persistent new muscle weakness and increased 
fatigue, characterising the post-polio syndrome. The patho-
genesis is not completely understood but thought to be 
related to a disturbance of the denervation/re-innervation 
equilibrium with further denervation. In 2016, it was esti-
mated that there are 15–20 million polio survivors world-
wide [76].
Enterovirus‑71(EV71)
This virus was isolated in 1969 and is a common cause of 
hand, foot, and mouth disease in children. Cyclical large 
epidemics occur in the Asian-Pacific region every 2–3 years 
and it circulates at a low level in the rest of the world, with 
small outbreaks in Europe, North America and Africa [130]. 
Children may develop CNS manifestations after 3–5 days of 
prodrome [100]. During an outbreak in Malaysia, 10–30% of 
hospitalised children had neurological manifestations, which 
included aseptic meningitis, encephalitis and acute flaccid 
Fig. 2  Timeline of important pandemics including key neurological complications. These are noted for the first pandemic caused by an infection
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paralysis secondary to anterior myelitis, GBS and trans-
verse myelitis [59]. The most common CNS manifestation 
is brainstem encephalitis, severely affecting the medulla and 
frequently evolving to cardiac dysfunction and neurogenic 
pulmonary oedema. Seizures may occur in children under 
two years. Myoclonic jerks are frequent in encephalitic 
cases. Up to one-fifth of children with severe neurological 
manifestations have sequelae, and only a quarter of those 
with brainstem encephalitis and cardiorespiratory failure 
have a full neurological recovery [20].
Variant Creutzfeldt‑Jakob (vCJD)
Bovine spongiform encephalopathy (BSE) was first 
described in 1985 and peaked in 1992/1993. The first cases 
of vCJD in humans were described in 1995 in the UK [149], 
and were found to be caused by the BSE prion [26]. vCJD 
affects a younger age group when compared to sporadic CJD 
with a median onset age of 26 years in the UK and 36 years 
in France [15]. The incubation period may be as long as 
15–20 years [27]. In the earliest phase of vCJD psychiatric 
features are prominent with depression, short-lived delusions 
and hallucinations being most common [15]. Over 60% of 
patients may have persistent painful sensory features which 
are frequently lateralised. The majority of patients present 
with cerebellar features 4 to 6 months after disease onset. 
Myoclonus is a late feature, occurring more 6 months after 
onset, and chorea, tremor and dystonia are also common at 
this stage. Oculomotor problems and complaints of diplopia 
may be present in half of patients [15]. All patients develop 
cognitive impairment (with initial symptoms being disori-
entation and poor memory) and eventually dementia. Pro-
gression to death occurs on average 14 months after disease 
onset.
Direct or indirect contact with infected individuals
Influenza
Influenza viruses can be divided in seasonal and pandemic. 
The seasonal influenza A viruses (H3N2 and H1N1) cause 
yearly epidemics, while pandemics of influenza are the con-
sequence of cross-species transmission, followed by adap-
tion to humans [77]. The CNS is the most common site of 
extra-respiratory complication of influenza infections [77]. 
Febrile seizures and encephalopathy are the most frequent 
neurological manifestations, affecting predominantly chil-
dren [137]. Other acute neurologic presentations include 
meningitis, encephalitis (including acute necrotising enceph-
alopathy and acute haemorrhagic leukoencephalopathy), 
and an increased frequency of ischaemic stroke, all during 
the acute disease [11, 137]. Influenza may also be associ-
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mitochondrial dysfunction and hepatic metabolic failure, 
triggered by drugs (especially aspirin) [121].
Late post infectious neurological complications of influ-
enza have been extensively reported and are more frequent 
in adults. These include including GBS, cerebellitis, Kleine-
Levin syndrome, myositis and transverse myelitis [137, 
150]. A link between encephalitis lethargica (von Economo 
disease) and influenza A has been suggested with an out-
break of encephalitis lethargica cases noted after the 1918 
Influenza pandemic [56]. During the acute phase, patients 
presented with excessive sleepiness, disorders of ocular 
motility, fever and movement disorders; frequently preceded 
by flu-like symptoms. The chronic phase typically devel-
oped 1–5 years after acute disease, but has been delayed 
by up to 45 years. Symptoms include Parkinsonism with 
psychiatric symptoms, abnormal ocular movements, speech 
abnormalities, spasticity and brisk reflexes; a constellation 
of symptoms memorably described by the neurologist Oli-
ver Sacks in his book “Awakenings” [114]. There remains 
controversy whether encephalitis lethargica is caused by 
direct CNS invasion by the influenza virus, or represents a 
virus-related autoimmune phenomenon [56]. Other cases of 
post-encephalitic Parkinsonism not related to encephalitis 
lethargica have been reported after influenza infections [61].
Coronaviruses
Since the beginning of the twenty-first century three corona-
viruses (CoV) have been responsible for pandemics; severe 
acute respiratory syndrome (SARS-CoV1) in 2003, Middle 
East respiratory syndrome (MERS-CoV) in 2012 and SARS-
CoV2 (also known as COVID-19) in 2019. Most human 
coronaviruses cause only mild respiratory symptoms and 
four strains are endemic worldwide, responsible for up to 
one third of upper respiratory tract infections in immuno-
competent individuals: HCoV-229E, -OC43, -NL63 and 
-HKU1 [32].
Coronaviruses can invade the CNS and have been associ-
ated with many neurological sequelae including demyelinat-
ing diseases [4], optic neuritis [33], and Parkinson disease 
[37]. HCov-OC43 was linked to a case of ADEM [160], 
fatal encephalitis in an immunodeficient child [91], and to a 
subset of Chinese children with encephalitis [75].
Sars‑CoV1
The 2002–2003 pandemic affected > 8000 people in 30 
countries, 10% of whom died [71]. SARS-Cov1 was found 
in CSF samples and brain tissue of encephalopathic patients 
with symptoms including seizures [72] and optic neuritis, 
manifesting in the acute phase [157]. Large artery ischaemic 
stroke were reported in 2.4% [141]. Neuromuscular disor-
ders including myopathy and axonal motor neuropathy were 
reported among critically ill patients, later during the course 
of the disease. However, it is not clear whether this is a con-
sequence of direct viral CNS infection, the host inflamma-
tory response, and/or immunologic processes [139].
MERS‑CoV
MERS has been an ongoing pandemic since initial reports in 
2012 and has already affected > 2500 people, 35% of which 
died [155]. In Saudi Arabia, seizures were reported during 
the acute phase, in > 8% of patients and confusion in > 25% 
[113]. ADEM, encephalitis and stroke (possibly due to vas-
culitis) have also been described [3]. Notably none of these 
conditions had MERS-CoV detected in CSF. A Korean study 
reported Bickerstaff’s brainstem encephalitis and polyneu-
ropathy among patients with MERS in the first few weeks 
of infection [64].
SARS‑CoV‑2
In December 2019, a new coronavirus appeared in Wuhan, 
China. A large current worldwide pandemic has resulted in 
six million recorded cases and over 1 million deaths, as of 
end of September 2020 [62]. Neurological complications 
of the disease have been reported and its mechanisms are 
still being scrutinised by the scientific community [36]. A 
retrospective Chinese study with 214 hospitalised patients 
described neurological features in just over one third of 
cohort, including dizziness, headaches and impaired con-
sciousness [83]. A French cohort of 58 critically ill patients 
reported encephalopathy and corticospinal signs. Brain MRI 
was performed in 13 patients, 8 of whom had leptomenin-
geal enhancement and 2 had acute ischaemic lesions [55]. 
There are reports of COVID patients with rhombencephalitis 
[151] and meningoencephalitis [159], some with positive 
Sars-CoV2 in the CSF [92], most of which presented with 
seizures and encephalopathy. Acute haemorrhagic leukoen-
cephalitis [108], demyelinating lesions [162], ADEM [102] 
and acute myelitis have also been reported [2]. Peripheral 
nervous system manifestations include anosmia/ageusia in 
over 80% of infected [73], GBS (both demyelinating and 
axonal) [138], Miller-Fisher syndrome (MFS) and isolated 
abducens palsies [48]. An increased frequency of acute 
cerebrovascular events among COVID patients is reported 
[101], at a similar frequency to previous studies of patients 
with sepsis [12]. This may be the consequence of a hyper-
coagulable state [164] related either to the viral infection or 
to the host response [97].
There are increasing reports of many patients suffering 
from a long-term syndrome lasting more than 3 months post 
infection which has been badged as “long COVID.” Neuro-
logical-type symptoms including neurocognitive difficulties, 
depression and other mental health conditions, peripheral 
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neuropathies and muscular weakness [46]. This is distinct 
from critical illness acquired weakness, and the neurocogni-
tive sequelae described in post intensive care syndrome [9], 
as the majority of the patients reporting this syndrome have 
not been hospitalised.
Ebola
First described in 1976, Ebola has caused several outbreaks, 
mainly in African countries, the largest in 2014–2016. Neu-
rological complications begin in the late stage when patients 
can have encephalopathy, seizures (probably due to meta-
bolic abnormalities), meningitis and meningoencephalitis 
[21]. The exact prevalence of neurological complications in 
the acute phase is unknown. The CNS may be a reservoir for 
Ebola virus; it was recovered from the CSF (at higher lev-
els than the blood) of an Ebola survivor 9 months after the 
patient’s recovery, when it then developed meningoencepha-
litis and radiculitis [60]. Long-term neurological sequelae 
are not uncommon among survivors, with memory loss in 
up to 40%, headaches in one third and muscle pain in 13% 
[128].
Measles
Until the introduction of attenuated measles vaccine, the 
disease killed 2–3 million people/year [154]. The mortality 
associated with measles decreased steadily since widespread 
vaccination programs were put in place in the beginning of 
the twenty-first century. However, since 2016, declining vac-
cination rates have resulted in epidemics in all WHO regions, 
including in previously measles-eradicated areas, like USA 
and Western Europe [104]. Though pneumonia is the main 
cause of death, severe CNS manifestations may occur. Pri-
mary measles encephalitis (PME) manifests during the 
exanthem due to direct CNS invasion with seizures, distur-
bances of consciousness and focal signs. Up to 15% of such 
patients die and a quarter have permanent neurological dam-
age [16]. The most frequent CNS complication of measles 
is acute post measles encephalitis, which occurs 2–30 days 
after infection and affects around 0.1% of children after a 
measles infection. Another complication is measles-induced 
ADEM, which begins weeks or months after rash clearance 
[16, 47]. Prognosis is better than with PME. Measles inclu-
sion body encephalitis (MIBE) is another complication, in 
which a progressive measles virus brain infection affecting 
patients with impaired cellular immunity, manifesting within 
1 year of the primary infection. It presents as altered con-
sciousness, refractory seizures and focal signs. Mortality is 
75% [16, 47]. Subacute sclerosing panencephalitis (SSPE) 
manifests 4–15 years after an acute measles infection, with 
a higher incidence in children who had the disease before 
the age of 5 [47]. SSPE is caused by persistence of a mutant 
measles virus after failure to completely clear the primary 
infection, and manifests initially as behavioural changes and 
cognitive decline, followed by myoclonic jerks, dyskinesias 
and ataxia, progressing to coma and death [16, 47]. Measles 
vaccination reduces SSPE incidence.
HIV/AIDS
Since the beginning of the pandemic in the 1980s, 75 million 
people have been infected with HIV, and 32 million have 
died [152]. While the introduction of combined antiretroviral 
therapies (cART) has decreased mortality and morbidity of 
acquired immunodeficiency syndrome (AIDS) and oppor-
tunistic infections (OI), the prevalence of complications 
associated with long-term HIV infections and its treatment 
have increased, particularly the neurologic ones [95]. Acute 
HIV infection can cause headache and neck stiffness second-
ary to aseptic meningitis [119].
The most common CNS OI are tuberculous meningoen-
cephalitis, neurotoxoplasmosis, cryptococcal meningitis, 
cytomegalovirosis and progressive multifocal leukoencepha-
lopathy (PML) secondary to JC virus [95]. Others include 
primary CNS lymphoma (associated with Epstein-Barr 
virus) and varicella-zoster vasculitis, with encephalopathy, 
cranial nerves palsies, strokes and seizures [119].
Immune reconstitution inflammatory syndrome (IRIS) 
may occur weeks to months after recovery from an immu-
nodeficient state. Low CD4 before initiation of cART is 
the strongest predictor of IRIS. It can affect any organ and 
CNS-IRIS prevalence is around 1%, occurring in response to 
dying opportunistic agents (frequently linked to Cryptococ-
cus or PML) or as a fulminant encephalitis associated with 
CD8 + T cells infiltration [95].
Up to 50% of HIV patients may be affected by HIV-asso-
ciated neurocognitive disorders (HAND) which range from 
asymptomatic to dementia [52]. HAND is a subcortical cog-
nitive disorder and presents with psychomotor retardation, 
executive dysfunction, deficits of working memory, retrieval, 
judgment, attention and impulse control, manifesting as a 
long-term complication of the infection. In the cART-era the 
incidence of HIV-related dementia has decreased to under 
5% [95], HIV disease markers are no longer closely related 
to cognitive impairment [50], and patients receiving cART 
have a better cognitive performance than patients who are 
cART-naïve [52]. This indicates that the pathophysiology 
of cognitive impairment may be related to the inflamma-
tory process which occurs in the presence of the virus in 
the CNS.
HIV infection can lead to a distal symmetric polyneu-
ropathy, which can be related both to neurotoxic antiret-
rovirals and to the viral infection per se, affecting small 
fibres and causing numbness and painful distal limbs symp-
toms. Polyneuropathy affects 30–70% of HIV patients and 
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immunosuppression no longer predicts its severity [103]. It 
may be related to neurotoxicity secondary to viral replica-
tion or to an immune reconstitution mechanism, damaging 
peripheral nerves and usually manifests in the chronic phase 
of the disease [95]. GBS (mainly demyelinating) has been 
associated with HIV very early in the infection [54].
HIV is independently associated with increased risk for 
stroke which may be secondary to viral effects on endothe-
lial dysfunction, vasculopathy and hyperviscosity [103]. 
Protease inhibitors used as antiretrovirals may also have a 
negative effect on vascular endothelial function.
Vacuolar myelopathy manifests in chronic AIDS [119]. 
An amyotrophic lateral sclerosis-like syndrome has been 
reported, and may resolve resolved after initiation of cART 
[95, 119]. Myopathy can occur regardless of the course of 
HIV infection, and is associated with direct virus lesion, 
inflammatory response, or ART (zidovudine) [95].
Other diseases and potential threats
Increases in global temperatures and a changing climate can 
lead to environmental adaptations of benefit for various dis-
ease vectors, including mosquitoes. These are the key vector 
for malaria, whose epidemic potential should increase in 
susceptible tropical countries (extending to highland areas) 
that had controlled the disease or be reintroduced in tem-
perate climates that had previously eliminated it. The most 
severe form of malaria (and cause of 500,000 deaths per 
year) is cerebral [107], affecting mainly young children dur-
ing the acute illness.
Yellow fever, another mosquito-borne virus, was a major 
threat to human health until the beginning of the twentieth 
century, having caused multiple epidemics and deaths in 
cities distant from endemic areas, in North America, the 
Caribbean and Europe [89]. The expansion of the disease to 
non-endemic areas means that susceptible non-vaccinated 
populations are now prone to new epidemics. The virus can 
rarely invade the CNS and cause encephalitis and meningitis 
early in the course of infection. Encephalopathy is also com-
mon in the context of hepatic failure of severe forms of the 
disease. Though extremely rare, yellow fever vaccine-asso-
ciated neurotropic disease is reported, causing encephalitis, 
GBS and ADEM [89].
The mosquito-borne dengue virus has expanded from a 
sporadic disease affecting 9 countries in the 1970s to being 
endemic in over 100 countries; half of the world is now 
at risk. Neurological complications can occur at any stage. 
Dengue encephalopathy is the most common and involves 
impaired consciousness in the context of shock, liver fail-
ure and electrolyte disturbances in the first 10 days of the 
disease. Meningitis and encephalitis due to CNS invasion of 
the virus are also possible, though rare, and patients present 
with decreased level of consciousness, headache, dizziness, 
seizures and focal signs, also in the acute phase. Post-dengue 
immune-mediated complications include GBS, transverse 
myelitis, ADEM, mononeuropathies of cranial nerves, optic 
neuropathy, muscle dysfunction and intracranial haemor-
rhages during the convalescence stage [17].
War, conflicts and natural disasters can facilitate the 
spread of diseases like cholera. Cholera has caused seven 
pandemics in the last two centuries. Electrolyte disturbances 
and hypoglycaemia (mainly in children) secondary to severe 
diarrhoea and acute dehydration can lead to symptomatic 
seizures [23]. Concurrent outbreaks of cholera and periph-
eral neuropathies have been described among undernour-
ished displaced populations, in the subacute phase of the 
disease [112].
The recent decrease in coverage of MMR (measles, 
mumps and rubella) vaccine in some areas has also led to an 
increase of cases of rubella and mumps. Mumps can cause 
aseptic meningitis and encephalitis in the early days of the 
disease and ADEM as a late post infectious complication [6]. 
The major neurological manifestation of rubella is the con-
genital rubella syndrome (CRS) in foetuses whose mothers 
are infected during pregnancy. CRS includes causes enceph-
alopathy, microcephaly and sensorineural hearing loss. 
Encephalitis has also been reported during the exantematic 
phase [6].
Smallpox was a cause of massive epidemics until its 
eradication in the 1980s by global immunisation programs. 
Since most of people living today are not vaccinated against 
it and the viable variola virus is still kept in two maximum 
security laboratories [87], it is feared that it could be used in 
bioterrorist attacks. Neurological complications of smallpox 
were uncommon and have been poorly studied, but descrip-
tions are compatible with demyelinating/inflammatory 
encephalomyelitis, 5 to 16 days after the acute disease [13]. 
Post-vaccination encephalomyelitis has also been described, 
mainly in young children [13].
Conclusion: preparing for the future
Pandemics and epidemics have been present for thousands 
of years, and have played a pivotal role in history. Much of 
previous focus has been on the acute illnesses themselves, 
with relatively little attention paid to the social, human and 
economic consequences of neurological sequelae. However, 
it is these sequelae that often lead to significant amounts of 
mortality and long-term morbidity.
Under-recognition of neurological manifestations means 
that few studies have been conducted in previous pandem-
ics to understand, treat and prevent neurological compli-
cations, and so the burden of secondary complications is 
even greater. With the recent developments in imaging, new 
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information about the presentation of CNS diseases is avail-
able and can assist in the proper diagnosis of neurologic 
manifestations of infectious diseases. However, even in 
developed countries, diagnostic tests are limited and treat-
ments are often inadequate or non-existent, with significant 
long-term economic and healthcare consequences. There-
fore, it is reasonable to expect that in low and middle-income 
countries with poorer access to diagnostic tests and treat-
ments, the neurological involvement by these diseases will 
have a greater economic impact. Potentially limiting future 
human capital by leaving long-term motor and cognitive 
impairments.
This urgent need to pay more attention to the short- and 
longer term sequelae of pandemics has been brought into 
sharp focus with COVID-19 where there have been numer-
ous reports of short-term sequelae and a growing apprecia-
tion of longer term problems. There is a growing recognition 
of the need to work globally with international collabora-
tions being formed to better understand the neurological 
consequences of COVID-19 [53]. These include (but are 
not exclusive to) the CoroNerve Study Group [143], Euro-
pean Academy of Neurology’s EAN Neuro-COVID Registry 
Consortium (ENERGY) [98], and the Global Consortium 
Study of Neurological Dysfunction in COVID-19 (GCS-
NeuroCOVID) [40].
However, it is also important to learn from previous pan-
demics to understand what to expect and plan responses to 
improve the outcomes. This knowledge of what has occurred 
the past is useful to highlight symptoms and signs to be 
vigilant for ensuring such sequelae are not missed. For 
example, encephalitis lethargica and post-encephalitic par-
kinsonism have been seen after viral infections, most notably 
the 1918–19 influenza pandemic [43]. Indeed, a case of par-
kinsonism in a patient post COVID-19 has been described, 
including a reduction of 18F-fluorodopa uptake bilaterally 
in the putamina [25], In the months to years following this 
pandemic it would be important to continue to look for such 
patients.
As new infections continue to emerge, new pandemics 
will certainly happen. Despite advances in the treatment of 
infectious diseases in the last century, those affecting the 
nervous system are still challenging. An improved under-
standing of the pathophysiology of neurologic damage and 
recognising its possible manifestations is fundamental to 
develop new treatments and management strategies.
Neurological involvement in pandemics and epidem-
ics is common and can cause devastating consequences 
amongst affected populations. There is an urgent need for 
better address this issue in pandemics, including the current 
SARS-CoV-2 outbreak.
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